New Diagnostic Tests in Glomerular Disease

New Diagnostic Tests in Glomerular Disease is organized by Baptist Health South Florida.

Course opens: 04/01/2016
Course expires: 04/01/2022

Target Audience:
Nephrologists, Emergency Medicine Physicians, Family Medicine Physicians, Internists, Hospitalists, Endocrinologists, Physician Assistants, Nurse Practitioners, Nurses, and other interested healthcare professionals are among those who will benefit from this plans.  

Course Description:
The diagnosis and treatment of Glomerular diseases has historically been a challenge for both patients and physicians. It is the gold standard for diagnosis to perform a kidney biopsy. Therapy is usually used to treat glomerular disease which are not unique to disease pathogenesis. Latest advancements in the understanding, diagnosis, and treatment of four glomerular diseases include:: immunoglobulin A nephropathy, focal segmental glomerulosclerosis, the C3 glomerulopathies, and idiopathic membranous nephropathy.

Learning Objectives:
• Determine and comprehend the mechanisms of suPAR in focal segmental glomerulosclerosis in chronic kidney disease, as well as the potential prognostic role of podocyte B7 staining.  
• Explain how anti-PLA2r antibodies are used in the diagnosis, prognosis, and treatment of membranous nephropathy.  
• Explain the future roles of galactose deficient IgA antibodies and OgG anti-IgA antibodies in the diagnosis and prognosis of IgA Nephropathy. 
• Describe the importance of complement levels and C3 levels in the development of glomerular diseases.